infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Services
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 21 articles from: HCV and coinfections

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • Temporary Decline in CD4 T-Cell Count After Hepatitis C Infection in PLWHIV

    Infectious Disease Advisor / 09 January 2019

  • Vosevi safe, effective in ‘triple-infected’ patients with HCV, HBV, HIV

    Healio / 15 October 2018

  • A strain of hepatitis found only in rats infected a Hong Kong man

    Quartz / 02 October 2018

  • How Well Do Docs Manage Potential Conflicts Between Hep C and HIV Meds?

    Manual Items / 10 April 2018

  • HCV Can Reactivate with Treatment of Non-hepatic Cancer

    MD Magazine / 05 February 2018

  • Targeting MSM with HIV: Treatment as Prevention in the Netherlands

    Healio Hepatology / 18 July 2017

  • No Consistent Pattern of HBV Reactivation With Direct-acting Antivirals for HCV

    Medscape (requires free registration) / 27 April 2017

  • European Medicines Agency warns of risk of hepatitis B re-activation with direct-acting antivirals for hepatitis C

    EMA / 07 December 2016

  • HCV Drugs May Reactivate HBV, FDA Warns

    Medscape (free registration required) / 06 October 2016

  • More than 2 million people co-infected with HIV and hepatitis C

    Manual Items / 08 March 2016

← First123Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
      • Transmission and prevention
      • Diagnosis and monitoring
      • Disease course and symptoms
      • HCV and coinfections
      • Living with HCV
      • Treatment issues
      • Side effects
      • Therapies
      • Liver transplants
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2017. All rights reserved. We are not responsible for the content of external websites.

We are grateful to Abbvie, Janssen, Merck and Gilead for funding infohep.org. Our funders have had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

NAM working with the World Hepatitis Alliance and the European Liver Patients Association

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//   www.worldhepatitisalliance.org   www.elpa-info.org